D1 S3:Recombinant Peptide Production and Host Cell Impurities Format: Presentations and a Panel Discussion with Q&A (Virtual and In-Person Attendees) This session examines best practices for controlling host cell impurities in recombinant peptide production, drawing on regulatory expectations and experience from 505(b)(2) applications and biologics (including insulins)
Regarding injection frequency, tirzepatides once-weekly injection method shows significant advantages in weight loss and glycemic control, improving patient compliance more effectively than daily injections, such as liraglutide
Scientific References Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics
We provide guidance on managing potential side effects for a comfortable treatment experience
If we want to reduce the unacceptable excess mortality in this group, we must prioritise new, effective measures like thisalso financially, says Anders Fink-Jensen